SELECTA BIOSCIENCES
Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.
SELECTA BIOSCIENCES
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.selectabio.com
Total Employee:
51+
Status:
Active
Contact:
(617) 923-1400
Email Addresses:
[email protected]
Total Funding:
320.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Selecta Biosciences
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Selecta Biosciences
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Post-IPO Equity - Selecta Biosciences
Polaris Partners
Polaris Partners investment in Series E - Selecta Biosciences
Sanofi Ventures
Sanofi Ventures investment in Series E - Selecta Biosciences
Sphera Funds Management
Sphera Funds Management investment in Series E - Selecta Biosciences
Eminent Venture Capital
Eminent Venture Capital investment in Series E - Selecta Biosciences
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series E - Selecta Biosciences
Leukon Investments
Leukon Investments investment in Series E - Selecta Biosciences
I2BF Global Ventures
I2BF Global Ventures investment in Series E - Selecta Biosciences
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-12-06 | Cyrus Biotechnology | Selecta Biosciences investment in Series B - Cyrus Biotechnology | 18 M USD |
Key Employee Changes
Date | New article |
---|---|
2021-09-20 | Selecta Biosciences Announces Appointment of Kevin Tan as Chief Financial Officer |
Official Site Inspections
http://www.selectabio.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109